56
Participants
Start Date
February 5, 2021
Primary Completion Date
November 14, 2024
Study Completion Date
November 14, 2024
Experimental - Probiotic
Patients in the experimental group will take one compound (pill) a day for 21 days, containing a 50% combination of two probiotics: Lactobacillus rhamnosus and Bifidobacterium longum, at a dose of 10\^9 cfu/day. The carrier of lyophilized probiotics is maltodextrin and the mixture is encapsulated in hypromellose capsules.
Placebo
Patients in the control group will take one unit of placebo a day for 21 days.
IVIRMA Valencia, Valencia
Collaborators (1)
ADM Protexin
INDUSTRY
Biopolis S.L.
INDUSTRY
Instituto Valenciano de Infertilidad, IVI VALENCIA
OTHER
Fundación IVI
OTHER